Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000712367 | SCV000344104 | uncertain significance | not provided | 2016-09-07 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000712367 | SCV000842841 | uncertain significance | not provided | 2018-05-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000712367 | SCV001017382 | benign | not provided | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV001195439 | SCV001365808 | benign | not specified | 2019-04-26 | criteria provided, single submitter | clinical testing | The p.Arg1177His variant in MYO6 is classified as benign because it has been identified in 0.3% (77/24958) of African chromosomes by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BA1. |
Gene |
RCV000712367 | SCV001813201 | likely benign | not provided | 2020-02-26 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004543130 | SCV004767565 | likely benign | MYO6-related disorder | 2019-12-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |